Ph1b Study of Oraxol in Comb. w. Ramucirumab in Patients w. Gastric, Gastro-esophageal, or Esophageal Cancers

Conditions:   Gastric Cancer;   Esophageal Cancer;   Gastro-esophageal Cancer
Interventions:   Drug: Oraxol;   Drug: Ramucirumab
Sponsor:   Kinex Pharmaceuticals Inc
Not yet recruiting - verified November 2016

http://ift.tt/2fnBZlu